Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1 | BMJ Case Reports

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Global health

Authors

About

Help
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Case report

Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1

Free

Online download statistics by month:

Online download statistics by month: April 2021 to March 2023

	Abstract	Full	Pdf
Apr 2021	650	615	231
May 2021	6653	6581	2173
Jun 2021	7830	7635	2953
Jul 2021	3980	3812	1127
Aug 2021	1402	1245	595
Sep 2021	1043	984	286
Oct 2021	744	719	328
Nov 2021	2231	2207	319
Dec 2021	696	675	178
Jan 2022	472	459	125
Feb 2022	315	304	97
Mar 2022	276	261	121
Apr 2022	238	226	74
May 2022	1839	1797	117
Jun 2022	345	303	76
Jul 2022	365	356	42
Aug 2022	229	212	51
Sep 2022	191	159	39
Oct 2022	163	131	44
Nov 2022	155	126	40
Dec 2022	109	93	21
Jan 2023	194	180	49
Feb 2023	196	162	41
Mar 2023	102	95	21
Total	30418	29337	9148